Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Disclosure under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 201504-05-2018
04-05-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Disclosure pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201520-04-2018
Announcement Under Regulation 30 (LODR)
Update on Divestment of the Company's Managed Healthcare Services Business in Kenya to Mayfair Healthcare Holdings Ltd.13-04-2018
Announcement Under Regulation 30 (LODR)
Update on Divestment of the Company's Managed Healthcare Services Business in Kenya to Mayfair Healthcare Holdings Ltd.13-04-2018
Shareholding for the Period Ended March 31, 2018
Bliss GVS Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here12-04-2018
Certification Under Clause 7 (3) Of The Listing Regulations For The Period 1St October, 2017 To 31St March, 2018.
Clause 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') for the period ended 31st March, 201809-04-2018
Certification Under Clause 40 (9) Of The Listing Regulations For The Period 1St October, 2017 To 31St March, 2018
Clause 40 (9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') for the period ended 31st March, 201809-04-2018
Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Mr. S. N. KamathDesignation :- Director09-04-2018
Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Mr. S. N. KamathDesignation :- Director09-04-2018
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Disclosure under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 201507-04-2018